FY26 Peer Reviewed Cancer Clinical Trial Award (CTA) for trials from phase 0 to phase III
This award funds the rapid implementation of cancer clinical trials that could meaningfully improve cancer treatment or management within specific PRCRP topic areas. Supported studies can test new drugs or biologics, devices, clinical guidance, or emerging approaches, spanning phase 0 through phase III. Projects must include patient advocates, must be clinical-trial focused (no animal studies …
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of Health ▸ National Cancer Institute
-
Spinal Cord Injury Clinical Trial Award to Rapidly Test New Treatments
Dept. of the Army -- USAMRAA
-
NCI R01 Clinical Trial Grant (Phase 0–IV) for Cancer Prevention and Control
National Institutes of Health ▸ National Cancer Institute
-
DOD Peer-Reviewed Cancer Clinical Development Award for Early-Career Fellows and Residents (FY25)
Dept. of the Army -- USAMRAA
-
Clinical Trials Network Award
Texas Grants
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers